David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
IMPORTANT: As of 8:00 AM on September 3, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Anjali Vaidya Offers Insight to MedPage Today on HYPERION Trial Findings, Study of Sotatercept in Pulmonary Arterial Hypertension Within One Year of Diagnosis
Posted October 3, 2025
Anjali Vaidya, MD, FACC, FASE, FACP, Director of the Advanced Pulmonary Hypertension, Right Heart Failure and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program at Temple University Hospital, offered insight to MedPage Today on findings from the HYPERION trial.
View DetailsDr. Sabrina Islam Shares Insight With Medscape on Two Studies Presented at the American Heart Association’s Hypertension Scientific Sessions
Posted September 18, 2025Sabrina Islam, MD, MPH, Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective to Medscape on two new studies presented at The American Heart Association’s Hypertension Scientific Sessions (HYP).
Read More